Medication Adherence and Healthcare Disparities: Impact of Statin Co-Payment Reduction
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
MetadataShow full item record
CitationLewey, Jennifer, William H. Shrank, Jerry Avorn, Jun Liu, and Niteesh K. Choudhry. 2015. Medication Adherence and Healthcare Disparities: Impact of Statin Co-Payment Reduction. Am. J. Manag. Care. 21(10): 696-704.
AbstractObjectives: Minority patients have lower rates of cardiovascularmedication adherence, which may be amenable to co-payment reductions.Our objective was to evaluate the effect of race on adherencechanges following a statin co-payment reduction intervention.Study Design: Retrospective analysis.Methods: The intervention was implemented by a large selfinsuredemployer. Eligible individuals in the intervention cohort(n = 1961) were compared with a control group of employees ofother companies without such a policy (n = 37,320). As a proxy forrace, we categorized patients into tertiles based on the proportionof black residents living in their zip code of residence. Analyseswere performed using difference-in-differences design with generalizedestimating equations.Results: Prior to the new co-payment policy, adherence rateswere higher for individuals living in areas with fewer black residents.In multivariable models adjusting for demographic factors,clinical covariates and baseline trends, the co-payment reductionincreased adherence by 2.0% (P = .14), 2.1% (P = .15) and 6% (P
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:33719951
- FAS Scholarly Articles